Nuclear imaging in cardiac amyloidosis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 4, 2009, Pages 702-714

  Glaudemans, A W J M ^a   Slart, R H J A ^a   Zeebregts, C J ^a   Veltman, N C ^a   Tio, R A ^a   Hazenberg, B P C ^a   Dierckx, R A J O ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Amyloidosis; Cardiology; Cardiology MIBG; Molecular imaging; Nuclear imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; APROTININ TC 99M; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MYOSIN ANTIBODY IN 111; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TECHNETIUM PHOSPHATE TC 99M; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG METABOLISM; HEART AMYLOIDOSIS; HEART VENTRICLE FUNCTION; HUMAN; MEDICAL ASSESSMENT; MEDICAL RESEARCH; NERVE ENDING; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE VENTRICULOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; AMYLOID; AMYLOIDOSIS; APROTININ; CARDIOLOGY; HEART DISEASES; HUMANS; INFLAMMATION; IODINE RADIOISOTOPES; MYOCARDIUM; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 62149105189     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1037-1     Document Type: Article

References (80)

1. JB Selvanayagam PN Hawkins B Paul 2007 Evaluation and management of the cardiac amyloidosis J Am Coll Cardiol 50 22 2101 2110
2. BP Hazenberg II van Gameren J Bijzet 2004 Diagnostic and therapeutic approach of systemic amyloidosis Neth J Med 62 4 121 128
3. P Westermark MD Benson JN Buxbaum 2005 Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 12 1 1 4
4. SW Dubrey K Cha J Anderson 1998 The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement QJM 91 141 157
5. SW Dubrey K Cha RW Simms 1996 Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis Am J Cardiol 77 313 315
6. MD Benson 2003 The hereditary amyloidosis Best Pract Res Clin Rheumatol 17 909 927
7. B Ng LH Connors R Davidoff 2005 Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis Arch Intern Med 165 1425 1429
8. V Camacho I Carrio 2007 Targeting neuronal dysfunction and receptor imaging Curr Opin Biotechnol 18 1 60 64
9. M Hongo K Urushibata R Kai 2002 Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis Am Heart J 144 1 122 129
10. S Yamashina J Yamazaki 2007 Neuronal imaging using SPECT Eur J Nucl Med Mol Imaging 34 Suppl 1 S62 73
11. T Nakata K Shimamoto S Yonekura 1995 Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-12-MIBG J Nucl Med 36 6 1040 1042
12. AS Arbab K Koizumi K Toyama 1997 Scan findings of various myocardial SPECT agents in a case of amyloid polyneuropathy with suspected myocardial involvement Ann Nucl Med 11 2 139 141
13. M Tanaka M Hongo O Kinoshita 1997 Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy J Am Coll Cardiol 29 1 168 174
14. N Delahaye S Dinanian MS Slama 1999 Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability Eur J Nucl Med 26 4 416 424
15. J Lekakis MA Dimopoulos V Prassopoulos 2003 Myocardial adrenergic denervation in patients with primary (AL) amyloidosis Amyloid 10 2 117 120
16. N Delahaye F Rouzet L Sarda 2006 Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy Medicine (Baltimore) 85 4 229 238
17. N Delahaye D Le Guludec S Dinanian 2001 Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy Circulation 104 2911 2916
18. Y Yazaki M Isobe W Takahashi 1999 Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123 I BMIPP SPECT: correlation with clinicopathological findings and clinical course Heart 81 2 153 159
19. F De Geeter PR Franken FF Knapp 1994 Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and I-beta-methyl-iodo-phenyl pentadecanoic acid Eur J Nucl Med 21 283 291
20. PR Franken F De Geeter P Dendale 1994 Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve J Nucl Med 35 1758 1765
21. T Nakata S Tanaka S Hamagami 1996 Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP J Nucl Med 37 1679 1681
22. AS Hambye AA Dobbeleir AM Vervaet 1999 BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction J Nucl Med 40 9 1468 1476
23. T Athanasoulis J Koutsikos LA Moulopoulos 2003 Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy Clin Nucl Med 28 8 631 635
24. 99mTc-(V) DMSA uptake in breast cancer Br Cancer Res 6 2 56 62
25. H Kobayashi H Sakahara T Itoh 1993 Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein J Nucl Med 34 5 815 817
26. H Ohta K Endo T Kanoh 1989 Technetium-99m (V) DMSA uptake in amyloidosis J Nucl Med 30 12 2049 2052
27. TC Yen KY Tzen KS Chen 2000 The value of gallium-67 and thallium-201 whole-body and single-photon emission tomography images in dialysis-related β2-microglobulin amyloid Eur J Nucl Med 27 1 56 61
28. YH Low ES Ang AS Goh 1995 Technetium-99m (Tc-99m) diphosphono- propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis - a case report Ann Acad Med Singapore 24 6 898 901
29. K Wechalekar FS Ng PA Poole-Wilson 2007 Cardiac amyloidosis diagnosed incidentally by bone scintigraphy J Nucl Cardiol 14 5 750 753
30. T Kobayashi M Sekiya Y Fujiwara 1993 A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation Ann Nucl Med 7 4 273 276
31. K Kodama M Hamada T Kuwahara 1999 Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis Int J Card Imaging 15 5 371 378
32. SM Sojan DR Smyth C Tsopelas 2005 Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin Nucl Med Commun 26 6 535-9
33. C Aprile G Marinone R Saponaro 1995 Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin Eur J Nucl Med 22 12 1393 1401
34. BK Schaadt HW Hendel P Gimsing 2003 99mTc-aprotinin scintigraphy in amyloidosis J Nucl Med 44 2 177 183
35. S Han V Chong T Murray 2007 Preliminary experience of 99mTc-aprotinin scintigraphy in amyloidosis Eur J Haematol 79 6 494 500
36. RW Kula WK Engel BR Line 1977 Scanning for soft-tissue amyloid Lancet 1 8002 92 93
37. M Puille K Altland RP Linke 2002 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy Eur J Nucl Med Mol Imaging 29 3 376 379
38. K Karp U Naslund C Backman 1987 Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy Int J Cardiol 14 3 365 369
39. H Leinonen KJ Totterman T Korppi-Tommola 1984 Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis Am J Cardiol 53 2 380 381
40. J Kulhanek A Movahed 2003 Uptake of technetium 99m HDP in cardiac amyloidosis Int J Cardiovasc Imaging 19 3 225 227
41. D Casset-Senon V Secchi P Arbeille 2005 Localization of myocardial amyloid deposits in cardiac amyloidosis by Tc-99m pyrophosphate myocardial SPECT: implication for medical treatment Clin Nucl Med 30 7 496 497
42. RH Falk VW Lee A Rubinow 1984 Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis Am J Cardiol 54 8 1150 1151
43. MA Ruder MA Alpert JF Sanfelippo 1984 Symptomatic cardiac amyloidosis in an American family South Med J 77 7 831 833
44. SM Sobol JM Brown SR Bunker 1982 Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy Am Heart J 103 4 Pt 1 563 566
45. S Schiff T Bateman R Moffatt 1982 Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease Am Heart J 103 4 Pt 1 562 563
46. A Ali DA Turner SW Rosenbush 1981 Bone scintigram in cardiac amyloidosis: a case report Clin Nucl Med 6 3 105 108
47. I Ak E Vardareli O Erdinc 2000 Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement Clin Nucl Med 25 10 826 827
48. C Fournier G Grimon JP Rinaldi 1993 Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography Am J Cardiol 72 11 854 857
49. M Hongo J Hirayama T Fujii 1987 Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy Am Heart J 113 3 654 662
50. RM Davidson DS Lin M Klima 1993 Temporal changes in myocardial uptake on serial bone scans in two cases of presumed senile cardiac amyloidosis Clin Nucl Med 18 10 858 862
51. SA Goldstein J Lindsay PL Chandeysson 1989 Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older Am J Cardiol 63 11 752 753
52. TA Wizenberg J Muz YH Sohn 1982 Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the non-invasive diagnosis of cardiac amyloidosis Am Heart J 103 4 Pt 1 468 473
53. RH Falk VW Lee A Rubinow 1983 Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis Am J Cardiol 51 5 826 830
54. VW Lee AG Caldarone RH Falk 1983 Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection Radiology 148 1 239 242
55. P Eriksson C Backman P Bjerle 1984 Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy Br Heart J 52 3 321 326
56. S Janssen DA Piers MH van Rijswijk 1990 Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis Eur J Nucl Med 16 8-10 663 670
57. A Hartmann J Frenkel R Hopf 1990 Is technetium-99m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis? Int J Card Imaging 5 4 227 231
58. E Perugini PL Guidalotti F Salvi 2005 Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy J Am Coll Cardiol 46 6 1076 1084
59. LR Bernstein 1998 Mechanisms of therapeutic activity for gallium Pharm Rev 50 4 665 682
60. SD Braun R Lisbona JA Novales-Diaz 1979 Myocardial uptake of 99mTc-phosphate tracer in amyloidosis Clin Nucl Med 4 6 244 245
61. J Montes L Lopez JL Chamorro 1984 Cardiac gallium uptake in amyloidosis Eur J Nucl Med 9 9 438
62. CK Li MA Rabinovitch JE Juni 1985 Scintigraphic characterization of amyloid cardiomyopathy Clin Nucl Med 10 3 156 159
63. D Jain JC Crawly A Lahiri 1990 Indium-111 antimyosin images compared with triphenyltetrazolium chloride staining in a patient six days after myocardial infarction J Nucl Med 31 231 233
64. I Carrio L Berna M Ballester 1988 Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection J Nucl Med 29 1893 1900
65. J Lekakis N Vassipoulos H Psichoyiou 1991 Doxorubicin cardiotoxicity detected by indium-111 myosin specific imaging Eur J Nucl Med 18 225 226
66. J Lekakis J Nanas C Moustafellou 1992 Cardiac amyloidosis detected by indium-111 antimyosin imaging Am Heart J 124 1630 1631
67. J Lekakis M Dimopoulos J Nanas 1997 Antimyosin scintigraphy for detection of cardiac amyloidosis Am J Cardiol 80 963 965
68. CN Aroney TD Ruddy H Dighero 1989 Differentiation of restrictive cardiomyopathy from pericardial constriction: assessment of diastolic function by radionuclide angiography J Am Coll Cardiol 13 1007 1014
69. MC Gerson MS Colthar NO Fowler 1989 Differentiation of constrictive pericarditis and restrictive cardiomyopathy by radionuclide ventriculography Am Heart J 118 114 120
70. IP Clements LJ Olson PD Scanlon 2000 The effect of respiration on left ventricular diastolic filling as assessed by radionuclide ventriculography Nucl Med Commun 21 55 63
71. M Hongo T Fujii J Hirayama 1989 Radionuclide angiographic assessment of left ventricular diastolic filling in amyloid heart disease: a study of patients with familial amyloid polyneuropathy J Am Coll Cardiol 13 48 53
72. G Palladini C Campana C Klersy 2003 Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis Circulation 107 2440 2445
73. A Dispenzieri MA Gertz RA Kyle 2004 Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation Blood 104 6 1881 1887
74. PN Hawkins JP Lavender MB Pepys 1990 Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component N Engl J Med 323 508 513
75. BP Hazenberg MH van Rijswijk DA Piers 2006 Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis Am J Med 119 355.e15 e24
76. PL Jager BP Hazenberg EJF Franssen 1998 Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value J Nucl Med 39 699 706
77. BP Hazenberg MH Van Rijswijk M Lub-de Hooge 2007 Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis J Nucl Med 48 6 865 872
78. S Yadav S Sharma I Gilfillan 2006 Unusual positron emission tomography findings in pulmonary amyloidosis: a case report J Cardiothorac Surg 1 32
79. WE Klunk H Engler A Nordberg 2004 Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 3 306 319
80. GD Rabinovici AJ Furst JP O'Neil 2007 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration Neurology 68 1205 1212